5-hydroxydopamine has been researched along with adenosine in 2 studies
| Studies (5-hydroxydopamine) | Trials (5-hydroxydopamine) | Recent Studies (post-2010) (5-hydroxydopamine) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
|---|---|---|---|---|---|
| 71 | 0 | 0 | 32,536 | 1,075 | 8,930 |
| Protein | Taxonomy | 5-hydroxydopamine (IC50) | adenosine (IC50) |
|---|---|---|---|
| high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
| Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
| Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
| Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
| Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
| Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Furukawa, T; Katsuragi, T; Mori, R | 1 |
2 other study(ies) available for 5-hydroxydopamine and adenosine
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Release of purines and noradrenaline from the vascular adrenergic nerves by 5- and 6-hydroxydopamine.
Topics: Adenosine; Animals; Calcium; Citalopram; Hydroxydopamines; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Norepinephrine; Oxidopamine; Potassium Chloride; Propylamines; Pulmonary Artery; Purines; Rabbits; Serotonin Antagonists | 1987 |